Homozygous Familial Hypercholesterolemia
📧 Sign up to get email alerts when something new happens for Homozygous Familial Hypercholesterolemia.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2016-07-11FDA Approved: JUXTAPID — Supplemental Application (Amryt Pharmaceuticals DAC)
FDA approves a supplemental application for JUXTAPID (lomitapide mesylate) submitted by Amryt Pharmaceuticals DAC, resulting in labeling cha…
-
FDA label_change · 2014-02-18FDA Approved: JUXTAPID — Supplemental Application (Amryt Pharmaceuticals DAC)
The FDA approved a supplemental application for JUXTAPID (lomitapide mesylate) submitted by Amryt Pharmaceuticals DAC, resulting in a labeli…